First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)

This study has been completed.

Sponsor:

Collaborators:

Fondazione Associazione Ricerca e Cura in Oncologia (ARCO)

Roche Pharma AG

Information provided by:

Gruppo Oncologico del Nord-Ovest

ClinicalTrials.gov Identifier:

NCT01163396

First received: July 9, 2010

Last updated: July 14, 2010

Last verified: July 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given